Heptares Therapeutics competitive analysis

Explore patent oppositions filed by Heptares Therapeutics against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
Method And Composition For Crystallizing G Protein-Coupled ReceptorsTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITYJan 22, 2016

Explore Heptares Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
Oct 22, 2025Use Of Glycopyrrolate For Treating Tachycardia1

Latest PTAB cases involving Heptares Therapeutics

Discover the latest PTAB cases involving Heptares Therapeutics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Heptares Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
HEPTARES THERAPEUTICS11 - -
TEVA PHARMACEUTICALS5201712
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY - 59 - 3